: Recognized for its strong clinical momentum in oncology and its leading HIV franchise, with consistent revenue growth reported recently. Global & High-Growth Tickers
: The global leader in animal health, currently ranked as an "undervalued" wide-moat stock by Morningstar.
: Holds a "Buy" rating with significant 1-year price target upside, largely due to its dominance in cystic fibrosis treatments. top pharma stocks to buy now
Best Pharmaceutical Stocks for 2026 and How to Invest in Them
: A staple for value investors, focusing on its next-generation immunology drugs to offset the patent loss of its blockbuster drug Humira. : Recognized for its strong clinical momentum in
: Frequently cited as a top pick for its leadership in the weight-loss market with Mounjaro and Zepbound . It remains the world's largest healthcare company by market cap.
AI responses may include mistakes. For financial advice, consult a professional. Learn more The Best Healthcare Stocks to Buy | Morningstar Best Pharmaceutical Stocks for 2026 and How to
: The top pick for those looking at Indian markets, cited as a long-term leader in specialty drugs.